Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study
单位：[1]Department of Hematology, Navy General Hospital of PLA, Beijing, China[2]School of Medicine, Nankai University, Tianjin, China[3]Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China[4]Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, China大连医科大学附属第一医院[5]Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China河南省肿瘤医院[6]Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China[7]Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China中国医科大学附属盛京医院[8]Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, China[9]Department of Hematology, The First Hospital, Jilin University, Changchun, China[10]Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China[11]Department of Hematology, Chinese PLA General Hospital, Beijing, China[12]Department of Hematology, China-Japan Friendship Hospital, Beijing, China[13]Department of Hematology, Beijing Hospital, National Center of Gerontology, Beijing, China[14]Department of Hematology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China[15]Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
第一作者单位：[1]Department of Hematology, Navy General Hospital of PLA, Beijing, China
推荐引用方式(GB/T 7714)：
Lixin Wang,Guofeng Chen,Jianliang Shen,et al.Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study[J].BLOOD.2018,132:doi:10.1182/blood-2018-99-111761.
APA：
Lixin Wang,Guofeng Chen,Jianliang Shen,Jianmin Luo,Meiyun Fang...&Li Yu.(2018).Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study.BLOOD,132,
MLA：
Lixin Wang,et al."Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study".BLOOD 132.(2018)
医学